Filtered By:
Condition: Heart Failure
Cancer: Cancer
This page shows you your search results in order of relevance. This is page number 11.
Order by Relevance | Date
Total 590 results found since Jan 2013.
Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells
We presently review the levels of S1P in those vascular and vascular-related diseases. Plasma S1P levels were reduced in various inflammation-related diseases such as atherosclerosis and sepsis, but were increased in other diseases including type 2 diabetes, neurodegeneration, cerebrovascular damages such as acute ischemic stroke, Alzheimer's disease, vascular dementia, angina, heart failure, idiopathic pulmonary fibrosis, community-acquired pneumonia, and hepatocellular carcinoma. Then, we highlighted the molecular mechanism by which S1P regulated EC biology including vascular development and angiogenesis, inflammation, p...
Source: Histology and Histopathology - February 4, 2022 Category: Cytology Authors: Yan Qiu Junyi Shen Wenli Jiang Yi Yang Xiaoheng Liu Ye Zeng Source Type: research
Comparing pharmacotherapy in MINOCA versus medically managed obstructive acute coronary syndrome
This study uniquely compares the management and outcomes of MINOCA patients with a medically managed obstructive ACS (M-ACS) population. We retrospectively analysed registry data for consecutive patients admitted to the Gold Coast University Hospital with ACS requiring coronary angiography and identified patients with MINOCA and M-ACS. Baseline characteristics, pharmacological therapy and in-hospital outcomes were compared. In hospital outcomes were composite NACE, heart failure, stroke and major bleeding. Multivariate regression analysis was also performed to identify independent predictors of MINOCA. Multivariate regress...
Source: Heart and Vessels - March 23, 2022 Category: Cardiology Source Type: research
Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study
CONCLUSIONS: Compared with persons without cancer, adult cancer survivors have significantly higher risk of CVD, especially HF, independent of traditional cardiovascular risk factors. There is an unmet need to define strategies for CVD prevention in this high-risk population.PMID:35772913 | DOI:10.1016/j.jacc.2022.04.042
Source: Atherosclerosis - June 30, 2022 Category: Cardiology Authors: Roberta Florido Natalie R Daya Chiadi E Ndumele Silvia Koton Stuart D Russell Anna Prizment Roger S Blumenthal Kunihiro Matsushita Yejin Mok Ashley S Felix Josef Coresh Corinne E Joshu Elizabeth A Platz Elizabeth Selvin Source Type: research
The Effect of Chronic Disease Management Program on the Risk of Complications in Patients With Hypertension in Korea
CONCLUSION: The results showed that participants of the chronic disease management program were less likely to have hypertension complications compared to non-participants. Enhancing the participation rate may be related to better outcomes and reducing medical expenses among patients with chronic diseases.PMID:35942556 | DOI:10.3346/jkms.2022.37.e243
Source: Cancer Control - August 9, 2022 Category: Cancer & Oncology Authors: Sang Ah Lee Hyeki Park Woorim Kim Sun Ok Song Hyunsun Lim Sung-Youn Chun Source Type: research
Prevalence of Cardiovascular Diseases Among Breast Cancer Survivors: Findings From the NHANES 2003-2018
CONCLUSION: Our findings suggest that BC survivors are at risk of suffering from CVD and public health strategies for the long-term management of CVD risk factors in this vulnerable population group is recommended.PMID:35975972 | DOI:10.1177/08901171221120910
Source: American Journal of Health Promotion : AJHP - August 17, 2022 Category: International Medicine & Public Health Authors: Youngdeok Kim R Lee Franco Alexander R Lucas Arnethea L Sutton Jessica G LaRose Jonathan Kenyon Jeremy Via Richard K Cheng Ralph B D'Agostino Vanessa B Sheppard W Gregory Hundley Source Type: research
Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases
Vasa. 2022 Oct 6. doi: 10.1024/0301-1526/a001031. Online ahead of print.ABSTRACT Vascular adhesion protein-1 (VAP-1) also known as amino oxidase copper containing 3 (AOC3) is a pro-inflammatory and versatile molecule with adhesive and enzymatic properties. VAP-1 is a primary amine oxidase belonging to the semicarbazide-sensitive amine oxidase (SSAO) family, which catalyzes the oxidation of primary amines leading to the production of ammonium, formaldehyde, methylglyoxal, and hydrogen peroxide. VAP-1 is mainly expressed by endothelial cells, smooth muscle cells, adipocytes and pericytes. It is involved in a repertoire of bi...
Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - October 6, 2022 Category: Surgery Authors: Marianna Danielli Roisin Clare Thomas Lauren Marie Quinn Bee Kang Tan Source Type: research
